AAC Funding Report Writing – 60 minutes
AAC report writing can seem like a daunting task whether you are writing your first report or have submitted reports in the past. There are several steps involved starting with device trials and moving towards writing a device submission report. What are the do's and don’ts of report writing? What is the language of report writing? How can our treatment plan on the report be used in our therapy plan and/or IEP to help the user acclimate to their device? In this presentation, participants will learn successful report writing tips for AAC device submissions. The resources, tools and strategies learned during this presentation can help a therapist during each stage of an AAC device funding report and treatment plan. During the presentation tools and strategies for having the most effective report will be discussed and examples demonstrated. These resources can be easily implemented into a clinician’s evaluation process when working with any AAC user. AAC Funding Report Writing Handout
Rachel Johnson has a Bachelor’s (BA) in Speech Pathology from Columbia College, Columbia, SC and a Masters in Communication Disorders (MCD) from the University Of South Carolina School Of Public Health.
Rachel has 12 years of experience in the field of speech language pathology and have worked as an expert with assistive technology since 2011. First serving as the Pediatric and Adult Neuro AAC Specialist for an outpatient rehabilitation center then transitioning to working with AT and ALS patients with the MN/ND/SD Chapter of the ALS Association's Herbek Sing AT Program, which led me to become the AT Program Manager of the DC/MD/VA Chapter of ALS Association. I am an experienced presenter, and I have presented at Closing the Gap, a national AT conference in 2013, 2014, 2015, 2016. During the last 2 years, I have presented at the Children’s Hospital AT Symposium, CollaborATe in Richmond, VA as well as a host of support groups, medical clinics, and in-services on the topic of AT/AAC for the ALS patient and/or other eye-gaze users.